Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.99
+0.07 (0.88%)
At close: Feb 21, 2025, 4:00 PM
8.27
+0.28 (3.53%)
After-hours: Feb 21, 2025, 7:59 PM EST
Novavax Employees
Novavax had 1,543 employees as of December 31, 2023. The number of employees decreased by 449 or -22.54% compared to the previous year.
Employees
1,543
Change (1Y)
-449
Growth (1Y)
-22.54%
Revenue / Employee
$573,683
Profits / Employee
-$184,613
Market Cap
1.28B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
NVAX News
- 1 day ago - Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - PRNewsWire
- 17 days ago - Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job - Reuters
- 17 days ago - Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary - CNBC
- 2 months ago - Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone - PRNewsWire
- 2 months ago - Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza - PRNewsWire
- 2 months ago - Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln - Reuters
- 2 months ago - Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million - PRNewsWire
- 3 months ago - Novavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript) - Seeking Alpha